Site Search

Turkey Is Ready for the New Century in the Treatment of Parkinson's and Movement Disorders

Under the auspices of Medipol Healthcare Group, Parkinson's and Movement Disorders Center (PARMER), which has been providing services since 2018, has signed a new protocol with the world-renowned neurosurgeon, Prof. Andres Lozano, who specializes in movement disorders diseases. Within the framework of this protocol, Prof. Lozano will not only accompany the new technologies offered to patients at the education, research, diagnosis, and treatment center PARMER, but also share his knowledge and experience in functional neurosurgery and movement disorders with young Turkish and foreign neurosurgeons and neurologists who aspire to specialize in this field and wish to gain experience in Turkey, at specific times.

Under the auspices of Medipol Healthcare Group, Parkinson's and Movement Disorders Center (PARMER), which gained the title of "Center of Excellence" and started providing services in 2018, continues to collaborate with world-renowned physicians. Recently, a protocol was signed on November 20th at Istanbul Medipol Mega University Hospital with Prof. Andres Lozano, the former Chair of the Department of Neurosurgery at the University of Toronto who is known for his focus on developing new treatments for functional neurosurgery and movement disorders and his academic contributions in this field. With this protocol, PARMER aims to not only host new technologies for the treatment of movement disorders but also create an arena where young healthcare professionals can meet and gain experience from world-renowned experts. This initiative is the first in the neighboring countries and the close geographical region in the field of Parkinson's and Movement Disorders.

"This is just the beginning," said Prof. Gazi Yiğitbaşı, the Medical Director of Medipol Mega University Hospital, in his speech at the signing ceremony, drawing attention to Turkey's global brand in the healthcare sector in its centennial year. He stated that with this protocol, they have made a groundbreaking move in the field of movement disorders, especially Parkinson's disease. He further added, "The step taken here today is actually just a beginning... As Medipol Healthcare Group, we are preparing to provide services in an independent 'International Neuromodulation and Movement Disorders Center,' in a unique 2,000-square-meter building in Istanbul, which will have no equivalent worldwide... While the preparations for the building are underway, PARMER will continue its international efforts at our new hospital in Istanbul Acıbadem."

"Knowledge and Experience Multiply as We Share"

Speaking at the ceremony, Prof. Lozano expressed his excitement about coming together with his expert colleagues and young healthcare professionals and candidates who are dedicated to functional neurosurgery in Istanbul, a city that connects two continents and is one of the most important destinations for medical tourism. He stated, "Today, PARMER stands out as a center of interest in its region and globally, with its team and efforts in all movement disorders diseases, especially Parkinson's. I would also like to underline that PARMER is a promising center in terms of both scientific research and patient treatment, considering its future goals. Being a part of this family is exciting for me, and I hope that we will collaborate on great projects, operations, and international partnerships."


About Andres M. Lozano, MD, PhD, FRCSC, FRSC, FCAHS

Dr. Lozano was born in Sevilla, Spain and moved with his family to Ottawa at a young age. He obtained his MD degree from the University of Ottawa and his PhD in Neurobiology and neurosurgical training from McGill University. He received postdoctoral training in movement disorders at Queen Square, London, UK and in cell and molecular biology in Toronto. He was appointed to the University of Toronto in 1991, and in 1999 he became the youngest individual to be appointed Full Professor in the Department of Surgery. In 2014 he was appointed to the rank of University Professor, the highest and most prestigious academic rank at the University of Toronto. He has held the position of Chairman of the Division of Neurosurgery at the University of Toronto the Dan Family Chair in Neurosurgery, and the  RR Tasker Chair in Functional Neurosurgery at University Health Network and a Tier 1 Canada Research Chair in Neuroscience. He currently holds the Alan and Susan Hudson Chair in Neurosurgery.

Dr. Lozano has an active laboratory dedicated to the study of neurodegeneration and functional neurosurgery. He has published over 800 manuscripts, 100 chapters and edited 5 books. He has the unique distinction of being named the most highly cited neurosurgeon in the world for each of 10 consecutive years 2014-2023 (Thompson Reuters, Clarivate). Dr. Lozano has been an invited speaker or visiting professor throughout the world, delivering over 500 lectures including 45 named lectures such as the Penfield, Marsden, Leksell, Feindel, Ojemann, Hunt-Wilson, Winn, Salk and Olivecrona lectures. He has served on the board and executive of several international organizations, including the founding scientific advisory board of the Michael J. Fox Foundation and the Weston Brain Institute, and has been President of both the American and World Society for Stereotactic and Functional Neurosurgery. He is editor-in-chief of the Textbook of Stereotactic and Functional Neurosurgery and currently serves on the international editorial board of 18 journals. He is editor in chief of the journal Stereotactic and Functional Neurosurgery.  Dr. Lozano is married and has two sons.

 Areas of Interest and Expertise

Dr. Lozano is best known for electrical recording and stimulation mapping of hitherto unexamined brain areas and for the identification and testing of novel therapeutic targets for deep brain stimulation (DBS). He and his team have pioneered the “first in man” applications of DBS in dystonia, Huntington’s, depression, anorexia and Alzheimer’s disease and locomotor brainstem areas in Parkinson’s disease. His recent work in experimental animals has shown that DBS can drive neurogenesis and enhance memory function. He is currently leading a large multicenter trial of DBS for Alzheimer’s disease. Dr. Lozano is particularly proud of the residents in the neurosurgery training program in Toronto and the more than 75 functional neurosurgery fellows that have trained with him and gone on to become leaders in their field.

20 November 2023, Monday